Literature DB >> 24694449

Remission of newly diagnosed immune thrombocytopenia after lung cancer resection.

Tatsuaki Watanabe1, Yuji Matsumura2, Muneo Minowa2, Hirotoshi Suzuki2, Hirotsugu Notsuda3, Yasuka Hara4, Satoru Kimura5, Yoshinori Okada6, Takashi Kondo6.   

Abstract

Secondary immune thrombocytopenia is a rare paraneoplastic syndrome of lung cancer. We report a case of pulmonary pleomorphic carcinoma with newly diagnosed secondary immune thrombocytopenia. On referral, the patient's complete blood cell count was normal; however, it showed marked thrombocytopenia after 1 month. Blood biochemistry and bone marrow puncture showed normal findings. We speculated that he had immune thrombocytopenia associated with the lung cancer and planned lung resection. Sleeve middle and lower lobectomy was successfully performed with preoperative intravenous immunoglobulin and intraoperative platelet transfusion. His platelet count was restored and maintained a normal level at 8 months after the operation.
Copyright © 2014 The Society of Thoracic Surgeons. Published by Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2014        PMID: 24694449     DOI: 10.1016/j.athoracsur.2013.12.069

Source DB:  PubMed          Journal:  Ann Thorac Surg        ISSN: 0003-4975            Impact factor:   4.330


  2 in total

1.  Paraneoplastic Evans syndrome in a patient with adenocarcinoma of the lung: A case report.

Authors:  Hong Yu; Rong Fu; Huaquan Wang; Hui Liu; Zonghong Shao
Journal:  Thorac Cancer       Date:  2016-11-16       Impact factor: 3.500

2.  Antigenic Mimicry in Paraneoplastic Immune Thrombocytopenia.

Authors:  Guillaume Vial; Etienne Rivière; Anne-Aurélie Raymond; Chloé James; Sylvaine Di-Tommaso; Nathalie Dugot-Senant; Jean-William Dupuy; Mokrane Yacoub; Marie Parrens; Fréderic Saltel; Jean-François Viallard
Journal:  Front Immunol       Date:  2019-03-22       Impact factor: 7.561

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.